Get Your Startup to the Next Level

The Merck Accelerator is looking for startups with the potential to reshape entire industries and make people's lives richer. The focus is on startups in the fields of healthcare, life science and performance materials - with a digital perspective. Do you have plans to internationalize your business? Are you ready to get your start-up to the next level?

The Merck Accelerator is looking for true innovators and entrepreneurs with a start-up mindset. Candidates applying to the accelerator program should be startups in the fields of healthcare, life science and performance materials who are dedicated to the program and ready to give their all for the entire program period.

Merck Accelerator Spring 2017 Application is now Open!

  • You are: A startup in the fields of Healthcare, Life Science and Performance Materials
  • Application: October 17, 2016 - December 19, 2016
  • Announcement: February 15, 2017
  • Program duration: March 6, 2017 - May 24, 2017

Here are the key benefits ready for you:
1. Financial support up to €50,000 for your team.
2. Accommodation & office space in the center of Darmstadt, Germany.
3. Access to a global network with 50,000+ industry leaders and investors.
4. Deep-dive mentoring sessions to bring your startup to the next level.
5. Travel & conference opportunities to enrich your international experience as well as the possibility to expand your network through our Silicon Valley extension program.

Here's the process:
1. Check the Merck Accelerator program, discover if we are the perfect fit for your startup.
2. Choose the location that you want to be part of.
3. Complete and submit the Darmstadt, Germany application form or Nairobi, Kenya application form by December 19, 2016.
4. After careful consideration of all aspects of each startup, the program participants will be chosen. You will get results by February 15, 2017. 5. Prepare to innovate, and change the world!

For further information, please visit:
http://accelerator.merckgroup.com

About Merck
Merck is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life - from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2015, Merck generated sales of € 12.85 billion in 66 countries.

Founded in 1668, Merck is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck, Darmstadt, Germany holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.

Most Popular Now

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Digital ECGs at Barts Health: A High-Imp…

Opinion Article by Dr Krishnaraj Sinhji Rathod, consultant in interventional cardiology, Barts Health NHS Trust. Picture the moment. A patient in an ambulance, enroute to hospital with new chest pain. Paramedics...

Study Sheds Light on Hurdles Faced in Tr…

Implementing artificial intelligence (AI) into NHS hospitals is far harder than initially anticipated, with complications around governance, contracts, data collection, harmonisation with old IT systems, finding the right AI tools...

Using Deep Learning for Precision Cancer…

Altuna Akalin and his team at the Max Delbrück Center have developed a new tool to more precisely guide cancer treatment. Described in a paper published in Nature Communications, the...

New AI Approach Paves Way for Smarter T-…

Researchers have harnessed the power of artificial intelligence (AI) to tackle one of the most complex challenges in immunology: predicting how T cells recognize and respond to specific peptide antigens...

Study Used AI Models to Improve Predicti…

Chronic kidney disease (CKD) is a complex condition marked by a gradual decline in kidney function, which can ultimately progress to end-stage renal disease (ESRD). Globally, the prevalence of the...

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...